Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03029286 · ClinicalTrials.gov registry record · NA
ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2
A NA study, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 995
- Enrollment target
NCT03029286: Completed NA study, sponsored by Georgetown University.
NCT03029286 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 995 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03029286, a NA study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 995 participants
- Enrollment target
Study Summary
This trial will test a decision support web based intervention for women at increased risk for breast cancer due to breast density and other risk factors (age, race/ethnicity, family history of breast cancer, history of prior breast biopsies), and to consider MRI and/or chemoprevention to manage their breast cancer risk.
Primary Outcome
Number of Participants who initiated chemoprevention is measured as receipt of any prescription for tamoxifen or raloxifene, based on health plan pharmacy data at any time from consent through 12 months.
Interventions
- BEHAVIORAL Usual Care Arm
- BEHAVIORAL Personalized Web Intervention Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 995 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2019-05-15 |
| Phase | NA |
What the finished NCT03029286 record still lists
NCT03029286 is an interventional study that assigns participants to a tested intervention. The registered 995 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care Arm is the first listed.
NCT03029286 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03029286 about?
NCT03029286 is a clinical study titled "ENGAGED 2 Study: Experiences With Mammography Screening and Breast Density 2". This trial will test a decision support web based intervention for women at increased risk for breast cancer due to breast density and other risk factors (age, race/ethnicity, family history of breast cancer, history of prior breast biopsies), and to consider MRI and/or chemoprevention to manage the...
What is the current status of trial NCT03029286?
This trial is currently completed. It is a NA study. The enrollment target is 995 participants. The study started on 2017-02-15. Estimated completion is 2019-05-15.
What interventions are being tested in trial NCT03029286?
The interventions under investigation include: Usual Care Arm (BEHAVIORAL), Personalized Web Intervention Arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT03029286?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03029286's enrollment target sits among peer trials
995 121st of 2000 higher than 1,880 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07005024 · 996 participants · Phase 3
DOAC - Dosing Options in AntiCoagulation Prophylaxis
- NCT05437575 · 994 participants · Phase 3
Prehospital Analgesia INtervention Trial (PAIN)
- NCT06671704 · 994 participants · NA
GC-PRO Intervention
- NCT05987241 · 992 participants · Phase 2
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI